Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trial Shows Cardiac Resynchronization Therapy Can Slow Heart Failure - Medical Product Outsourcing

What are you searching for?

Sign in

Trial Shows Cardiac Resynchronization Therapy Can Slow Heart Failure

Boston Scientific study shows a 29 percent reduction in death or heart failure interventions.

By: Editor

NULL

A trial sponsored by Boston Scientific Corporation has concluded that early intervention with cardiac resynchronization therapy can slow the progression of heart failure, according to the Natick, Mass.-based company.

Preliminary results find that using Boston Scientific cardiac resynchronization therapy defibrillators result in a 29 percent reduction in death or heart failure interventions when compared to traditional implantable cardioverter defibrillators.

The trial, called, MADIT-CRT, included more than 1,800 patients enrolled at 110 centers in 14 countries. The trial is being conducted under the leadership of Dr. Arthur J. Moss, professor of medicine at the University of Rochester Medical Center in Rochester, N.Y.

“We are very encouraged by these initial positive results, and we are hopeful they will eventually lead to a wider population of heart failure patients being treated with CRT-D therapy,” said Fred Colen, executive vice president and group president of Cardiac Rhythm Management at Boston Scientific.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters